Prosecution Insights
Prosecution Insights
163 pending office actions • 90 clients • 149 examiners • 81 art units • 0 of 163 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 69 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 69 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (1%) |
| §101 + other | 25 (15%) |
| §103 only | 29 (18%) |
| §102 only | 2 (1%) |
| §112 only | 14 (9%) |
| Double-patenting only | 7 (4%) |
| Double-patenting + other | 19 (12%) |
| Multi-statute (no §101) | 65 (40%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 3 | 42.7% | +67.3% |
| PETRASH, HILARY ANN | 2 | 63.9% | +53.5% |
| NERANGIS, VICKEY M | 2 | 56.5% | +29.1% |
| BROWN, DALIYAH MONYHE | 2 | 100.0% | +0.0% |
| CHESTNUT, BARRY A | 2 | 73.4% | +6.3% |
| NATARAJAN, MEERA | 2 | 62.3% | +17.6% |
| SCOTLAND, REBECCA LYNN | 2 | 0.0% | +0.0% |
| FORD, VANESSA L | 2 | 39.0% | +40.1% |
| LEE, JIA-HAI | 2 | 49.7% | +47.9% |
| BRISTOL, LYNN ANNE | 2 | 63.5% | +39.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17562316 | METHOD FOR CONTROLLING AN EYE SURGICAL LASER, COMPUTER PROGRAM PRODUCT, AND TREATMENT APPARATUS | CHRISTIANSON, SKYLAR LINDSEY | 282d overdue |
| 17641376 | METHOD OF PRODUCING LYOPHILIZED CELLS | BEHARRY, ZANNA MARIA | 201d overdue |
| 18258502 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | VIJAYARAGHAVAN, JAGAMYA NMN | 98d overdue |
| 17907162 | NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS | GORDON, MELENIE LEE | 60d overdue |
| 18433839 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER | OKONAK, ELIZABETH LOUISE | 49d overdue |
| 19169222 | DEVICES AND METHODS FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR REDUCING GEOMETRIC IRREGULARITIES OF AN EYE | WELCH, HALLE MARGARET | 43d overdue |
| 18005917 | STIMULATION ARRANGEMENTS, VENTILATION ARRANGEMENT, STIMULATION METHODS AND VENTILATION METHOD | REDDY, SUNITA | 43d overdue |
| 18436918 | METHOD FOR DETERMINING AN OPTIMIZED SPATIAL PULSE DISTANCE OF LASER PULSES FOR AN OPHTHALMOLOGICAL LASER | MORALES, JON ERIC C | 38d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18320599 | TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | BRISTOL, LYNN ANNE | 23d overdue |
| 18405772 | HIGH CONCENTRATION SOLUTION ANTIBODY FORMULATIONS COMPRISING ANTI-IL-23p19 ANTIBODIES | FORD, VANESSA L | 3d overdue |
| 18675357 | CELLULOSIC COMPOSITE | NERANGIS, VICKEY M | 33d |
| 18969940 | ANTI-PSMA ANTIBODY CONJUGATES | PETRASH, HILARY ANN | 41d |
| 18675209 | CELLULOSIC COMPOSITE | NERANGIS, VICKEY M | 75d |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | SINGH, ANOOP KUMAR | 84d |
| 18971848 | ANTI-CLAUDIN-6 CONJUGATES | PETRASH, HILARY ANN | — |
| 18699059 | ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS | NATARAJAN, MEERA | — |
| Art Unit | Apps |
|---|---|
| 3796 | 8 |
| 3791 | 7 |
| 3792 | 6 |
| 1632 | 6 |
| 1644 | 4 |
| 1672 | 4 |
| 1674 | 4 |
| 1654 | 4 |
| 1693 | 3 |
| 1615 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19228139 | RESOURCE-SAVING CLOSURE DEVICE | BERICAP Holding GmbH | SMALLEY, JAMES N | §102§103§112 | Non-Final OA | — | Pending | Jun 04, 2025 | |
| 19198975 | COMBINATION THERAPY USING A CD47-SIRP alpha BLOCKING AGENT AND AZACITIDINE | Aurigene Discovery Technologies Limited | HIBSHMAN, SARAH GRACE | 1693 | §102§103§112Other | Non-Final OA | 16d overdue | Pending | May 05, 2025 |
| 19169222 | DEVICES AND METHODS FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR REDUCING GEOMETRIC IRREGULARITIES OF AN EYE | Schwind Eye-Tech-Solutions GmbH | WELCH, HALLE MARGARET | 3796 | §101§102§103§112 | Non-Final OA | 43d overdue | Pending | Apr 03, 2025 |
| 19107911 | INSPECTION SYSTEM AND METHOD FOR A CLOSED MEDICAL CONTAINER | Hoffmann-La Roche, Inc. | AKANBI, ISIAKA O | §102 | Non-Final OA | — | Pending | Feb 28, 2025 | |
| 19103358 | PACKAGING MEMBER FOR A PHOTOSENSITIVE DRUG SUBSTANCE | Hoffmann-La Roche, Inc. | GEHMAN, BRYON P | 3736 | §102§103§112 | Non-Final OA | 16d | Pending | Feb 12, 2025 |
| 18976605 | TELESCOPIC EXTENSION WITH QUICK-FASTENING ELEMENTS | Accuride International GmbH | AYRES, TIMOTHY MICHAEL | 3637 | §102§112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18872988 | EVALUATION OF CONVERGENCE TIME AND ADJUSTMENT BASED ON EVALUATION OF CONVERGENCE TIME | Mercedes-Benz Group AG | BEDEWI, RAMI NABIH | 3666 | §101§102§103 | Non-Final OA | 84d | Pending | Dec 09, 2024 |
| 18971848 | ANTI-CLAUDIN-6 CONJUGATES | Adc Therapeutics SA | PETRASH, HILARY ANN | 1644 | §103DP | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18969940 | ANTI-PSMA ANTIBODY CONJUGATES | Adc Therapeutics SA | PETRASH, HILARY ANN | 1644 | §103Other | Non-Final OA | 41d | Pending | Dec 05, 2024 |
| 18869443 | RESPIRATION PROMOTING APPARATUS | Stimit AG | SAHAND, SANA | §103§112 | Non-Final OA | — | Pending | Nov 26, 2024 | |
| 18946353 | INFORMATION PROCESSING METHOD, NON-TRANSITORY STORAGE MEDIUM, AND INFORMATION PROCESSING APPARATUS | Tsz Tat Chu | MAHROUKA, WASSIM | §101§103§112 | Non-Final OA | — | Pending | Nov 13, 2024 | |
| 18934488 | OBLIQUE SPINAL FUSION CAGE | L&K Biomed Co., Ltd. | WEISS, JESSICA | 3775 | §102§103§112 | Final Rejection | — | Pending | Nov 01, 2024 |
| 18260000 | ARTIFICIAL-INTELLIGENCE-BASED CERVICAL CANCER SCREENING SERVICE SYSTEM | Ntl Healthcare Co.,Ltd. | CAMMARATA, MICHAEL ROBERT | §103§112 | Non-Final OA | — | Pending | Sep 06, 2024 | |
| 18841618 | TOPICAL COMPOSITIONS AND USES THEROF | Topadur Pharma AG | SHTERENGARTS, SAMANTHA L | §103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 | |
| 18798864 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Entera Bio Ltd. | PALENIK, JEFFREY T | 1615 | §102§103DP | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18776688 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | HOUGH, JESSANDRA F | 3796 | §101§103 | Non-Final OA | 29d | Pending | Jul 18, 2024 |
| 18772698 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS, CONTROL DEVICE THEREFOR, TREATMENT APPARATUS, COMPUTER PROGRAM PRODUCT AND COMPUTER-READABLE MEDIUM | Schwind Eye-Tech-Solutions GmbH | MARSH, OWEN LEWIS | 3796 | §101§102§103§112 | Non-Final OA | 29d | Pending | Jul 15, 2024 |
| 18728675 | FUNCTIONALIZED AMINOTHIAZOLES | Leadxpro AG | REDWOOD, CHRISTOPHER EVAN | §103 | Non-Final OA | — | Pending | Jul 12, 2024 | |
| 18766913 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | HILSMIER, HEIDI ANN | 3796 | §101§102§103 | Non-Final OA | 34d | Pending | Jul 09, 2024 |
| 18760523 | FIBER-OPTICAL SENSOR SYSTEM FOR ULTRASOUND SENSING AND IMAGING | Deepsight Technology, Inc. | PLUMB, NIGEL H | 2855 | DP | Non-Final OA | — | Pending | Jul 01, 2024 |
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | Octane Biotech Inc. | HENKEL, DANIELLE B | 1799 | §102§103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18717592 | COMPOSITE PRODUCT | Woodcomposite Sweden AB | SHEWAREGED, BETELHEM | 1785 | §102§103§112 | Non-Final OA | 21d | Pending | Jun 07, 2024 |
| 18678376 | DNA-BASED ADAPTOME PROFILING FOR MINIMAL RESIDUAL DISEASE QUANTIFICATION IN LYMPHOID MALIGNANCIES | Milaboratories Inc. | HORTH, LISA ANNE | 1681 | §112 | Final Rejection | 16d overdue | Pending | May 30, 2024 |
| 18675209 | CELLULOSIC COMPOSITE | Woodcomposite Sweden AB | NERANGIS, VICKEY M | 1763 | §103Other | Non-Final OA | 75d | Pending | May 28, 2024 |
| 18675357 | CELLULOSIC COMPOSITE | Woodcomposite Sweden AB | NERANGIS, VICKEY M | 1763 | §103Other | Final Rejection | 33d | Pending | May 28, 2024 |
| 18712828 | STABLE INJECTABLE COMPOSITIONS OF GLP-2 PEPTIDE | Orbicular Pharmaceutical Technologies Private Limited | BROWN, DALIYAH MONYHE | §102§103§112Other | Non-Final OA | — | Pending | May 23, 2024 | |
| 18710511 | RECOMBINANT FOOT-AND-MOUTH DISEASE TYPE A VIRUS INDUCING STRONG ADAPTIVE IMMUNE RESPONSE AND OVERCOMING INTERFERENCE FROM MATERNALLY-DERIVED ANTIBODIES, AND FOOT-AND-MOUTH DISEASE VACCINE COMPOSITION COMPRISING SAME | Republic Of Korea(Animal And Plant Quarantine Agency) | CHESTNUT, BARRY A | 1672 | §101§112 | Non-Final OA | — | Pending | May 15, 2024 |
| 18710537 | RECOMBINANT FOOT-AND-MOUTH DISEASE VIRUS TYPE O FOR INDUCING ROBUST ADAPTIVE IMMUNE RESPONSE AND OVERCOMING MATERNALLY-DERIVED ANTIBODY INTERFERENCE, AND FOOT-AND-MOUTH DISEASE VACCINE COMPOSITION COMPRISING SAME | Republic Of Korea(Animal And Plant Quarantine Agency) | CHESTNUT, BARRY A | §101§112 | Non-Final OA | — | Pending | May 15, 2024 | |
| 18651998 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHAMOLOGICAL LASER OF A TREAMENT APPARATUS FOR CORRECTING AN ASTIGMATISM | Schwind Eye-Tech-Solutions GmbH | HODGE, LAURA NICOLE | 3792 | §101§102§103§112 | Non-Final OA | 9d | Pending | May 01, 2024 |
| 18705292 | MICROFLUIDIC CELL CULTURING DEVICE | UNIVERSITÄT BERN | BRIDGES, DONAVAN LEE | §103 | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18705155 | FLEXIBLE SCOPE DEVICE | Hiang Khoon Tan | STARKEY, OLIVIA GRACE | 3795 | §102§103§112 | Final Rejection | — | Pending | Apr 26, 2024 |
| 18636185 | LIQUID FORMULATIONS OF TRAZODONE | Rubicon Research Private Limited | ROBINSON, MIKHAIL O'DONNEL | 1627 | §102§103§112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18632522 | R-FADROZOLE FOR USE IN THE TREATMENT OF ALDOSTONERISM | Damian Pharma AG | ROZOF, TIMOTHY R | 1625 | DP | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18699059 | ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS | UNIVERSITY OF OTTAWA | NATARAJAN, MEERA | §112 | Non-Final OA | — | Pending | Apr 05, 2024 | |
| 18626497 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR CORRECTING A CORNEA | Schwind Eye-Tech-Solutions GmbH | DOWNEY, JOHN R | 3792 | §101§103§112 | Non-Final OA | 19d overdue | Pending | Apr 04, 2024 |
| 18698193 | ULTRASOUND BEACON VISUALIZATION WITH OPTICAL SENSORS | Deepsight Technology, Inc. | KLEIN, BROOKE L | 3797 | §103§112 | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18619890 | SPRAYABLE LIQUID SPIRONOLACTONE COMPOSITIONS | Celista Pharmaceuticals LLC | SCOTLAND, REBECCA LYNN | 1615 | §103§112Other | Final Rejection | — | Pending | Mar 28, 2024 |
| 18695801 | METATARSAL IMPLANT | Episurf Ip-Management AB | WATKINS, MARCIA LYNN | 3774 | §103DP | Final Rejection | — | Pending | Mar 26, 2024 |
| 18682241 | ANALYTICAL METHODS FOR BACTERIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TESTING IN BIOLOGICAL SAMPLES | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA | CRUM, MARY ABOU NADER | 1657 | §103 | Final Rejection | — | Pending | Mar 19, 2024 |
| 18604899 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER | Schwind Eye-Tech-Solutions GmbH | LEE, ERICA SHENGKAI | 3796 | §101§102 | Non-Final OA | 61d | Pending | Mar 14, 2024 |
| 18687169 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | Genomatica, Inc. | SAIDHA, TEKCHAND | 1652 | §112 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18685985 | MULTI-DIMENSIONAL SIGNAL DETECTION WITH OPTICAL SENSORS | Deepsight Technology, Inc. | BRYANT, CHRISTIAN THOMAS | 3619 | §101§102§103 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18584528 | ELECTRONIC DEVICE FOR DETERMINING A LAMENESS PARAMETER AND RELATED METHODS | Delaval Holding AB | XU, JUSTIN | 3791 | §101 | Final Rejection | 15d overdue | Pending | Feb 22, 2024 |
| 18683932 | STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF | Sun Pharmaceutical Industries, Ltd. | BECKHARDT, LYNDSEY MARIE | 1613 | §103§112DPOther | Non-Final OA | 70d | Pending | Feb 15, 2024 |
| 18683943 | STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF | Sun Pharmaceutical Industries, Ltd. | SCOTLAND, REBECCA LYNN | 1615 | §103§112Other | Final Rejection | 70d | Pending | Feb 15, 2024 |
| 18440340 | LONG GERMLINE DH GENES AND LONG HCDR3 ANTIBODIES | Trianni, Inc. | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18436918 | METHOD FOR DETERMINING AN OPTIMIZED SPATIAL PULSE DISTANCE OF LASER PULSES FOR AN OPHTHALMOLOGICAL LASER | Schwind Eye-Tech-Solutions GmbH | MORALES, JON ERIC C | 3796 | §101§103§112Other | Non-Final OA | 38d overdue | Pending | Feb 08, 2024 |
| 18433839 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER | Schwind Eye-Tech-Solutions GmbH | OKONAK, ELIZABETH LOUISE | 3792 | §101§102§103§112 | Non-Final OA | 49d overdue | Pending | Feb 06, 2024 |
| 18432185 | TREATMENT OF HYPOPARATHYROIDISM | Entera Bio Ltd. | REYNOLDS, FRED H | 1658 | §103Other | Final Rejection | 30d overdue | Pending | Feb 05, 2024 |
| 18427293 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF | MedImmune, LLC | PUTTLITZ, KARL J | 1642 | DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18293761 | Substituted Isoindoline-1, 3-diketone PDE4 Inhibitor and Pharmaceutical Application Thereof | Suzhou Intragrand Pharma Co., Ltd. | CHAO, ALLEN | 1622 | §102§103 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18292730 | ELECTRONIC CONVERSION KIT FOR A MOTOR VEHICLE IN WHICH AN INTERNAL COMBUSTION ENGINE IS EXCHANGED FOR AN ELECTRIC TRACTION DRIVE HAVING AN ELECTRIC MOTOR, MOTOR VEHICLE HAVING THE CONVERSION KIT AND OPERATING METHOD FOR THE CONVERSION KIT | E-R3Volt GmbH | WANG, HARRY Z | 2184 | §103 | Final Rejection | 15d overdue | Pending | Jan 26, 2024 |
| 18292538 | GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF | Xiamen University | WANG, RUIXUE | 1672 | §103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18292242 | MEDICAL DELIVERY DEVICE | Hoffmann-La Roche, Inc. | FORD, RENE D | 3741 | §102§112 | Non-Final OA | 40d | Pending | Jan 25, 2024 |
| 18421663 | DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES | VENN BIOSCIENCES CORPORATION | SCHULTZHAUS, JANNA NICOLE | 1685 | §103§112Other | Final Rejection | 8d overdue | Pending | Jan 24, 2024 |
| 18291725 | TEAR-OPEN STRIP FOR A PACKAGING AND METHOD FOR PRODUCING A TEAR-OPEN STRIP | Mayr-Melnhof Karton AG | ZHANG, MICHAEL N | 1781 | §103 | Non-Final OA | 32d overdue | Pending | Jan 24, 2024 |
| 18417883 | STABILIZER POSTS FOR SCAFFOLD HOIST | Safe-T-Scaff Inc. | PEZZLO, BENJAMIN ALEXANDER | 3634 | §102§103 | Non-Final OA | 9d | Pending | Jan 19, 2024 |
| 18405772 | HIGH CONCENTRATION SOLUTION ANTIBODY FORMULATIONS COMPRISING ANTI-IL-23p19 ANTIBODIES | Merck Sharp & Dohme LLC | FORD, VANESSA L | 1674 | §112Other | Non-Final OA | 3d overdue | Pending | Jan 05, 2024 |
| 18576511 | DOWN FORCE CONTROL IN AN AGRICULTURAL IMPLEMENT | Väderstad Holding AB | SCOVILLE, BLAKE E | 3671 | §103§112 | Non-Final OA | 16d | Pending | Jan 04, 2024 |
| 18403384 | SHARED ELECTRIC BIKE WITH INTEGRATED FRAME AND LAMPS | VEORIDE INC. | LEE, MATTHEW D | 3617 | §102§103 | Final Rejection | 11d overdue | Pending | Jan 03, 2024 |
| 18394869 | HER2/neu-Specific Antibodies and Methods of Using Same | Tersera Therapeutics LLC | NATARAJAN, MEERA | §103DP | Non-Final OA | — | Pending | Dec 22, 2023 | |
| 18572508 | COMPOSITION FOR DETECTING MICROBIAL ON-SITE CONTAMINATION AND USE THEREOF | BIONANO HEALTH GUARD RESEARCH CENTER | GOLDBERG, JEANINE ANNE | 1682 | §102§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18545392 | NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS | UNIVERSITÄT BERN | LEE, JIA-HAI | 1658 | §102§103§112DP | Final Rejection | — | Pending | Dec 19, 2023 |
| 18571164 | PRPF31 VARIANT AND USES THEREOF | Chigenovo Co., Ltd. | YU, DAVID TUYANG | §103 | Non-Final OA | — | Pending | Dec 15, 2023 | |
| 18539883 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER FOR PROVIDING A TRANSITION ZONE BETWEEN INTERFACES | Schwind Eye-Tech-Solutions GmbH | MALAMUD, DEBORAH LESLIE | 3792 | §101§102 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18533836 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | Qiagen GmbH | CROW, ROBERT THOMAS | §103 | Final Rejection | — | Pending | Dec 08, 2023 | |
| 18526732 | TREATMENT OF NEUROLOGICAL DISORDERS | UNIVERSITÄT BASEL | HOWELL, THEODORE R | 1628 | §112Other | Non-Final OA | 28d | Pending | Dec 01, 2023 |
| 18560137 | IMMUNOGENIC COMPOSITION | Griffith University | PEEBLES, KATHERINE | 1617 | §101§102§103§112Other | Non-Final OA | 22d overdue | Pending | Nov 10, 2023 |
| 18502863 | TOPICAL OXYBUTYNIN FOR HOT FLASHES | Celista Pharmaceuticals LLC | BRAM, STANLEY | 1691 | §103 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | Trianni, Inc. | SINGH, ANOOP KUMAR | 1632 | §102§112 | Non-Final OA | 84d | Pending | Oct 26, 2023 |
| 18557451 | AN AIR TREATMENT ELEMENT, AN AIR TREATMENT UNIT AND A METHOD FOR PRODUCING THE AIR TREATMENT ELEMENT | Munters Europe Aktiebolag | JONES, CHRISTOPHER P | 1776 | §102§103 | Non-Final OA | 14d | Pending | Oct 26, 2023 |
| 18555183 | METHOD FOR CONDUCTING A PRE-CHARGING PROCESS OF AN ONBOARD ELECTRICAL SYSTEM OF A VEHICLE, AND ONBOARD ELECTRICAL SYSTEM FOR A VEHICLE | Schaeffler Technologies AG & Co. Kg | ORTIZ, ELIM | §102§103 | Non-Final OA | — | Pending | Oct 12, 2023 | |
| 18484921 | MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | Macrogenics, Inc. | BRISTOL, LYNN ANNE | 1643 | §103§112Other | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18286301 | LAYER COMPOSITE FOR USE AS AN IMITATION LEATHER | Nuvi Releaf GmbH | SALVATORE, LYNDA | 1789 | §103 | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18480841 | METHODS FOR CHARACTERIZING LENTIVIRUSES | Lonza Houston, Inc. | ALAM, DANYAL HASSAN | 1672 | §103§112 | Final Rejection | 23d overdue | Pending | Oct 04, 2023 |
| 18373470 | EDGE PROTECTION MOUNTING DEVICE IN A SYSTEM FOR SHEET COIL PACKAGING | Lamiflex Group AB | HIBBERT, MARY C | 3731 | §101§112DP | Non-Final OA | — | Pending | Sep 27, 2023 |
| 18552338 | MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS | Iosbio Ltd. | LY, KRISTINA ELISABETH | 1671 | §103 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18454930 | CARBON-SOURCE REGULATED PROTEIN PRODUCTION IN A RECOMBINANT HOST CELL | LONZA LTD | MEAH, MOHAMMAD Y | 1652 | DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18237675 | 4-THIOCARBAMOYLPHENYL 2-(4-OXOPHENYL)-PHENYL PROPANOATE FOR THE TREATMENT OF PAIN ASSOCIATED WITH UROLOGIC CHRONIC PELVIC PAIN SYNDROME | Antibe Therapeutics Inc. | HIRAKIS, SOPHIA P | 1623 | §102§112DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18277161 | METHOD AND A SENSOR FOR DETERMINING A CONCENTRATION OF A TARGET GAS IN THE BLOOD OF AN ANIMATE BEING | Albert-Ludwigs-Universität Freiburg | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Final Rejection | — | Pending | Aug 14, 2023 |
| 18546131 | EXTRACELLULAR VESICLE LINKED TO A BIOLOGICALLY ACTIVE MOLECULE VIA AN OPTIMIZED LINKER AND AN ANCHORING MOIETY | Lonza Sales AG | LEWOCZKO, EVAN MICHAEL | 1612 | §103DP | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18264831 | METHOD FOR MODULATING AFUCOSLYATION OF AN ANTIBODY PRODUCT | Lonza Biologics PLC | KIM, TAEYOON | 1631 | §102§103§112 | Final Rejection | 37d overdue | Pending | Aug 09, 2023 |
| 17906177 | EXTRACELLULAR VESICLES FOR TREATING NEUROLOGICAL DISORDERS | Lonza Sales AG | LEE, JIA-HAI | 1658 | §101§102§103DP | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | Octane Biotech Inc. | MUTREJA, JYOTI NAGPAUL | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18261934 | PROCESS FOR PREPARING METAL OXIDE NANOSHEETS | Royal Melbourne Institute Of Technology | NGUYEN, CAM N | 1736 | §103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18260150 | PROTECTIVE MASK COMPRISING A CONDUCTOR FABRIC | Avibas AG | BOECKER, JOSEPH D | 3785 | §102§103§112 | Non-Final OA | 16d overdue | Pending | Jun 30, 2023 |
| 18343296 | METHOD FOR ISOLATING RNA WITH HIGH YIELD | Qiagen GmbH | OLSON, ANDREA STEFFEL | 1693 | §102§103§112Other | Non-Final OA | 4d overdue | Pending | Jun 28, 2023 |
| 18343087 | PHARMACEUTICAL FORMULATION FOR TREATMENT OF CEREBRAL STROKE | Pharmazz, Inc. | HOWARD, ZACHARY C | 1674 | §103§112Other | Non-Final OA | 22d overdue | Pending | Jun 28, 2023 |
| 18342492 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | Sustain Holdings, LLC | BROWN, DALIYAH MONYHE | 1654 | §101§102Other | Non-Final OA | — | Pending | Jun 27, 2023 |
| 18259238 | CHEMICAL INDUCTION METHOD FOR PHOTORECEPTOR NEURON CELLS | Iregene Therapeutics Ltd. | MONTANARI, DAVID A | 1632 | §112 | Non-Final OA | — | Pending | Jun 23, 2023 |
| 18268933 | Composition Comprising Calcium Orthophosphate and a Bioactive Glass Comprising Fluorine | Queen Mary University Of London | LIU, TRACY | 1614 | §103 | Final Rejection | 38d overdue | Pending | Jun 21, 2023 |
| 18258684 | CHARGING DEVICE AND METHOD FOR CHARGING AN ELECTRICAL STORED ENERGY SOURCE OF AN ELECTRICALLY OPERABLE VEHICLE | Brusa Technology AG | KIK, PHALLAKA | 2851 | §102 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18338860 | TOPICAL NAFTIFINE COMPOSITIONS | Taro Pharmaceutical Industries Ltd. | BARSKY, JARED | 1628 | §103 | Final Rejection | — | Pending | Jun 21, 2023 |
| 18258502 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | Prime Vector Technologies GmbH | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §101§102§103§112 | Final Rejection | 98d overdue | Pending | Jun 20, 2023 |
| 18257762 | DRIVE UNIT FOR AN ELECTRIC TOOTHBRUSH HANDPIECE, ELECTRIC TOOTHBRUSH HANDPIECE, METHOD FOR PRODUCING OF AN ELECTRIC TOOTHBRUSH HANDPIECE, ATTACHMENT BRUSH FOR AN ELECTRIC TOOTHBRUSH HANDPIECE, AND ELECTRIC TOOTHBRUSH | Trisa Holding AG | JENNINGS, MICHAEL DEANGILO | 3723 | §102§103§112 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18253853 | NUCLEIC ACID DUPLEXES | Alpha Anomeric SAS | GROOMS, TIFFANY NICOLE | 1637 | §112 | Non-Final OA | — | Pending | May 22, 2023 |
| 18321354 | Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of Disease | Macrogenics, Inc. | MOSELEY II, NELSON B | 1642 | DP | Non-Final OA | — | Pending | May 22, 2023 |
| 18320599 | TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | Macrogenics, Inc. | BRISTOL, LYNN ANNE | 1643 | DP | Final Rejection | 23d overdue | Pending | May 19, 2023 |
| 18252277 | NICLOSAMIDE NASAL AND THROAT SPRAY | Needham Material Science LLC | NOLAN, JASON MICHAEL | 1623 | §102§103§112 | Non-Final OA | 84d | Pending | May 09, 2023 |
| 18251450 | ENDODEVICE | UNIVERSITÄT BASEL | WALKER, OLIVIA | 3796 | §102§103 | Non-Final OA | — | Pending | May 02, 2023 |
| 18250010 | ANTI-CD73 ANTIBODY AND USE THEREOF | Akeso Pharmaceuticals, Inc. | SKELDING, ZACHARY S | 1644 | §102§112DP | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18300994 | METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS | Lonza Walkersville, Inc. | MCCORMICK, CATHERINE LYNN | 1638 | §103Other | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18247961 | IMMUNOTHERAPY FOR THE TREATMENT OF CANCER | Targimmune Therapeutics AG | HUDSON, AMY ROSE | 1636 | §103§112Other | Non-Final OA | 23d | Pending | Apr 05, 2023 |
| 18247552 | STERILE SAMPLING METHODS AND DEVICES FOR AUTOMATED CELL ENGINEERING SYSTEMS | Lonza Walkersville, Inc. | LALONDE, ALEXANDRA ELIZABETH | 3783 | §102§103§112 | Non-Final OA | 23d overdue | Pending | Mar 31, 2023 |
| 18247406 | TEMPERATURE CALIBRATION METHODS AND DEVICES FOR USE IN AUTOMATED BIOREACTORS | Lonza Walkersville, Inc. | HASSAN, LIBAN M | 1799 | §103§112 | Non-Final OA | 3d overdue | Pending | Mar 30, 2023 |
| 18246432 | STIMULATION DEVICE | Stimit AG | LANDEEN, BROGAN RANE | 3791 | §102§103 | Final Rejection | — | Pending | Mar 23, 2023 |
| 18246403 | STIMULATION DEVICE AND METHOD OF STIMULATING A NERVE | Stimit AG | LANDEEN, BROGAN RANE | 3791 | §102§103§112 | Non-Final OA | 11d overdue | Pending | Mar 23, 2023 |
| 18246401 | STIMULATION DEVICE AND METHOD OF STIMULATING A NERVE | Stimit AG | LANNU, JOSHUA DARYL DEANON | 3791 | §102§103 | Final Rejection | 35d overdue | Pending | Mar 23, 2023 |
| 18246301 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | Lonza Sales AG | BREWSTER, HAYDEN R | 1779 | §103 | Final Rejection | 44d overdue | Pending | Mar 22, 2023 |
| 18245739 | SHAVING COMPOSITION | Fallien Cosmeceuticals, Ltd. | PRAGANI, RAJAN | 1614 | §102§103§112 | Final Rejection | — | Pending | Mar 17, 2023 |
| 18180789 | IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING | VENN BIOSCIENCES CORPORATION | XU, XIAOYUN | 1797 | §102§103Other | Final Rejection | 28d | Pending | Mar 08, 2023 |
| 18024927 | COMPOSITION CONTAINING AMMONIUM POLYPHOSHATE | Chemische Fabrik Budenheim Kg | USELDING, JOHN E | 1763 | §103 | Non-Final OA | — | Pending | Mar 06, 2023 |
| 18042068 | METHODS OF TREATING CANCER | Lonza Sales AG | STOICA, ELLY GERALD | 1647 | §103DP | Final Rejection | — | Pending | Feb 17, 2023 |
| 18169936 | IDENTIFICATION, CONFIGURATION AND CONTROL OF AN ELECTRIC APPLIANCE | Einhell Germany AG | FUREMAN, JARED | 2859 | DP | Final Rejection | — | Pending | Feb 16, 2023 |
| 18006294 | METHODS FOR THE USE OF A PD-1 X CTLA-4 BISPECIFIC MOLECULE | Macrogenics, Inc. | YU, MISOOK | 1641 | §102§103§112DPOther | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18005917 | STIMULATION ARRANGEMENTS, VENTILATION ARRANGEMENT, STIMULATION METHODS AND VENTILATION METHOD | Stimit AG | REDDY, SUNITA | 3791 | §103§112 | Final Rejection | 43d overdue | Pending | Jan 18, 2023 |
| 18005401 | PHARMACEUTICAL COMPOSITIONS | Extrovis AG | HA, JULIE | 1654 | §102§103 | Non-Final OA | — | Pending | Jan 13, 2023 |
| 18003872 | CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM | Institute Of Biophysics, Chinese Academy Of Sciences | SKOKO III, JOHN JOSEPH | 1643 | §103§112DP | Final Rejection | — | Pending | Dec 29, 2022 |
| 18000799 | ANTI-TRANSFERRIN EXTRACELLULAR VESICLES | Lonza Sales AG | FONTAINHAS, AURORA M | 1675 | §103§112 | Non-Final OA | — | Pending | Dec 05, 2022 |
| 18061728 | METHOD FOR CONTROLLING A LASER OF A LASER DEVICE, METHOD FOR PERFORMING A SURGICAL PROCEDURE, LASER DEVICE, COMPUTER PROGRAM AND COMPUTER-READABLE MEDIUM | Schwind Eye-Tech-Solutions GmbH | EISEMAN, LYNSEY C | 3796 | §102§103§112 | Non-Final OA | 35d overdue | Pending | Dec 05, 2022 |
| 17999775 | FORMULATIONS FOR VIRAL VECTORS | LONZA LTD | GU, QINHUA | 1633 | §103 | Final Rejection | — | Pending | Nov 23, 2022 |
| 18057709 | COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS | Lonza Sales AG | CARTER, SANDRA DILLAHUNT | 1674 | §112 | Final Rejection | — | Pending | Nov 21, 2022 |
| 18050017 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103DP | Non-Final OA | — | Pending | Oct 26, 2022 |
| 17936027 | METHODS FOR PROCESSING AND ANALYZING CELL-DERIVED VESICLES | Mdimune Inc. | MARTIN, PAUL C | 1653 | §103 | Non-Final OA | — | Pending | Sep 28, 2022 |
| 17936020 | METHODS FOR PROCESSING AND ANALYZING EXTRACELLULAR VESICLES | Exosomics Spa | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Non-Final OA | 1d overdue | Pending | Sep 28, 2022 |
| 17907162 | NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS | King'S College Hospital Nhs Foundation Trust | GORDON, MELENIE LEE | 1651 | §101§103§112 | Final Rejection | 60d overdue | Pending | Sep 23, 2022 |
| 17821945 | Use of Pharmaceutical Compositions of a HER2/neu Antibody | Tersera Therapeutics LLC | KIM, YUNSOO | 1641 | §112 | Non-Final OA | 20d | Pending | Aug 24, 2022 |
| 17904346 | PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCH | Leadxpro AG | DEBERRY, REGINA M | 1647 | §112 | Final Rejection | — | Pending | Aug 16, 2022 |
| 17760381 | NANOPARTICLES ENCAPSULATING SMALL MOLECULES | ETH ZÜRICH | DABKOWSKI, ERINNE R | 1654 | §112DPOther | Non-Final OA | — | Pending | Aug 09, 2022 |
| 17759714 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | VENN BIOSCIENCES CORPORATION | SABOUR, GHAZAL | 1686 | §101§103DP | Final Rejection | — | Pending | Jul 28, 2022 |
| 17795513 | DIAGNOSTIC REAGENT FOR QUANTITATIVE DETERMINATION OF PROCALCITONIN IN A SAMPLE | Diasys Diagnostic Systems GmbH | IVICH, FERNANDO NMN | 1678 | §112 | Non-Final OA | — | Pending | Jul 26, 2022 |
| 17793788 | DENTAL RESTORATION SYSTEM AND METHOD OF BUILDING A RESTORATION | Institut Straumann AG | MORAN, EDWARD JOHN | 3772 | §103§112 | Non-Final OA | 27d | Pending | Jul 19, 2022 |
| 17758535 | PEG-MODIFIED POLYPEPTIDE CAPABLE OF INHIBITING GP96, PREPARATION METHOD THEREFOR AND USE THEREOF | Beijing Cominghealth Bio Tec Co., Ltd. | LIEB, JEANETTE M | 1654 | §103§112 | Non-Final OA | — | Pending | Jul 08, 2022 |
| 17787793 | Therapy for the Treatment of Cancer | Macrogenics, Inc. | LUNDE, GRACE HENRY | 1641 | §103§112Other | Final Rejection | 34d | Pending | Jun 21, 2022 |
| 17757345 | AUTOMATED PRODUCTION OF VIRAL VECTORS | Lonza Sales AG | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Jun 14, 2022 |
| 17782429 | SYRINGE AND TIGHTNESS TESTING METHOD | Hoffmann-La Roche, Inc. | FARRAR, LAUREN PENG | 3783 | §102§112 | Non-Final OA | — | Pending | Jun 03, 2022 |
| 17751984 | END-TO-END CELL THERAPY AUTOMATION | Octane Biotech Inc. | HASSAN, LIBAN M | 1636 | §101§102§103§112 | Non-Final OA | — | Pending | May 24, 2022 |
| 17747851 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | VENN BIOSCIENCES CORPORATION | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112DP | Non-Final OA | — | Pending | May 18, 2022 |
| 17768610 | End-to-End Platform for Human Pluripotent Stem Cell Manufacturing | Lonza Walkersville, Inc. | ROGERS, ERIC JASON | 1638 | §103§112 | Non-Final OA | 49d | Pending | Apr 13, 2022 |
| 17641376 | METHOD OF PRODUCING LYOPHILIZED CELLS | LONZA LTD | BEHARRY, ZANNA MARIA | 1632 | §103§112 | Non-Final OA | 201d overdue | Pending | Mar 08, 2022 |
| 17688788 | BIOMARKERS FOR DETERMINING AN IMMUNO-ONCOLOGY RESPONSE | VENN BIOSCIENCES CORPORATION | BEVERIDGE, CONNOR HAMMOND | 1687 | §101§103§112 | Non-Final OA | — | Pending | Mar 07, 2022 |
| 17634897 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | Lonza Sales AG | MEJIAS, SAMANTHA LEE | 1618 | §103DP | Final Rejection | 3d overdue | Pending | Feb 11, 2022 |
| 17626351 | COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES | Xiamen Innovax Biotech Co., Ltd. | JONES, DAMERON LEVEST | 1618 | §112Other | Final Rejection | — | Pending | Jan 11, 2022 |
| 17562316 | METHOD FOR CONTROLLING AN EYE SURGICAL LASER, COMPUTER PROGRAM PRODUCT, AND TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | CHRISTIANSON, SKYLAR LINDSEY | 3792 | §102§112 | Non-Final OA | 282d overdue | Pending | Dec 27, 2021 |
| 17620615 | METHOD FOR SEPARATING NUCLEIC ACID MOLECULES BY SIZE | Qiagen GmbH | LAFAVE, ELIZABETH ROSE | 1684 | §102§103Other | Final Rejection | — | Pending | Dec 17, 2021 |
| 17620612 | METHOD FOR ENRICHING NUCLEIC ACIDS BY SIZE | Qiagen GmbH | BRANDSEN, BENJAMIN MICHAEL | 1693 | §103Other | Non-Final OA | 72d overdue | Pending | Dec 17, 2021 |
| 17603921 | Methods for Treatment of Subjects with Psoriatic Arthritis | Sun Pharmaceutical Industries, Ltd. | FORD, VANESSA L | 1674 | §112 | Non-Final OA | — | Pending | Oct 14, 2021 |
| 17594401 | METHODS OF TREATING TUBERCULOSIS | Lonza Sales AG | JUEDES, AMY E | 1644 | §103DP | Final Rejection | 1d overdue | Pending | Oct 14, 2021 |
| 17594054 | IMMUNOTHERAPY FOR THE TREATMENT OF CANCER | Targimmune Therapeutics AG | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103§112DP | Non-Final OA | — | Pending | Sep 30, 2021 |
| 17441162 | EXTRACELLULAR VESICLE CONJUGATES AND USES THEREOF | Lonza Sales AG | ANTHOPOLOS, PETER | 1611 | §103§112DP | Non-Final OA | 17d overdue | Pending | Sep 20, 2021 |
| 17433971 | BIOMARKERS FOR DIAGNOSING OVARIAN CANCER | VENN BIOSCIENCES CORPORATION | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | 1d overdue | Pending | Aug 25, 2021 |
| 17402730 | COMPOSITIONS COMPRISING SHORT-ACTING BENZODIAZEPINES | Paion UK Limited | MCDOWELL, BRIAN E | 1624 | — | Non-Final OA | 12d | Pending | Aug 16, 2021 |
| 17414730 | VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSION | Saiba AG | BUCKMASTER, MARLENE VRENI | 1672 | §103§112Other | Final Rejection | — | Pending | Jun 16, 2021 |
| 17338408 | ENHANCED PRODUCTION OF IMMUNOGLOBULINS | Trianni, Inc. | NICOL, ALEXANDER W | 1634 | §103§112 | Non-Final OA | 61d | Pending | Jun 03, 2021 |
| 17278866 | SSI CELLS WITH PREDICTABLE AND STABLE TRANSGENE EXPRESSION AND METHODS OF FORMATION | Pfizer, Inc. | LEONARD, ARTHUR S | 1631 | §103§112 | Non-Final OA | — | Pending | Mar 23, 2021 |
| 17136165 | CLEAR LACROSSE HEAD | East Coast Dyes, Inc. | KLAYMAN, AMIR ARIE | 3711 | §103§112 | Final Rejection | — | Pending | Dec 29, 2020 |
| 17254737 | FORCE SENSING DEVICE, MEDICAL ENDODEVICE AND PROCESS OF USING SUCH ENDODEVICE | UNIVERSITÄT BASEL | HOFFPAUIR, ANDREW ELI | 3791 | §103 | Non-Final OA | 60d overdue | Pending | Dec 21, 2020 |
| 17088759 | ALLOGENEIC T-CELLS AND METHODS FOR PRODUCTION THEREOF | Lonza Israel Ltd. | BUTTICE, AUDREY L | 1647 | §103§112 | Final Rejection | 42d | Pending | Nov 04, 2020 |
| 16486363 | MULTI-SITE SPECIFIC INTEGRATION CELLS FOR DIFFICULT TO EXPRESS PROTEINS | Pfizer, Inc. | SINGH, ANOOP KUMAR | 1632 | §112Other | Non-Final OA | — | Pending | Aug 15, 2019 |
| 16478461 | PASSAGING AND HARVESTING FORMULATION FOR SINGLE-CELL HUMAN PLURIPOTENT STEM CELLS | Lonza Walkersville, Inc. | EBBINGHAUS, BRIANA NOEL | 1632 | §103 | Non-Final OA | — | Pending | Jul 16, 2019 |
| 16472750 | LASER DEVICE AND TISSUE CHARACTERIZING METHOD | Advanced Osteotomy Tools - Aot AG | MULLINS, JESSICA LYNN | 3792 | §103 | Final Rejection | 26d | Pending | Jun 21, 2019 |
| 16146030 | PERFUSION APPARATUS FOR USE IN BIOREACTOR SYSTEMS | LONZA LTD | BOWERS, NATHAN ANDREW | 1799 | §103§112 | Non-Final OA | — | Pending | Sep 28, 2018 |
| 15125863 | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | Qiagen GmbH | POPA, ILEANA | 1633 | §103§112 | Non-Final OA | — | Pending | Sep 13, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial